Welichem Biotech Inc. announces changes to Board of Directors
Welichem Biotech Inc. announced changes to its Board of Directors. The Company increased the number of Directors on its Board from six to seven and appointed Mr. Weihe Wang, a representative from Celestial Pharmaceuticals (Shenzhen) Ltd, to the Board.
Mr. Wang Weihe is an entrepreneur with broad business experience in natural health products, pharmaceuticals and real estate development. He started his career in the natural health products business 20 years ago. He is now the Chairman of Board and CEO of Weihe Pharmaceutical Co. Ltd., a pharmaceutical manufacturer with more than 60 approved pharmaceutical products in China and Southeast Asia markets. He is Chairman of Celestial Pharmaceuticals (Shenzhen) Ltd., a fully integrated pharmaceutical research and development company with investments in drug developments in both China and Canada. Mr. Wang is also Chairman of Weihe Real Estate Development Co. Ltd. and Weihe Food Stuff Co. Ltd. China.
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.